Company Filing History:
Years Active: 2023-2025
Title: Innovations of Julia Rozenfeld
Introduction
Julia Rozenfeld is a prominent inventor based in Gordon, Australia. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 4 patents to her name, her work has the potential to impact various medical conditions.
Latest Patents
One of her latest patents is focused on Anti-PAR-2 antibodies and methods of use thereof. This patent provides antibodies and antigen-binding fragments that specifically bind to human PAR-2. The disclosed antibodies can block the interaction between a PAR-2 activating ligand and the extracellular domain of PAR-2. This innovation has implications for treating diseases associated with increased expression of PAR-2, including airway diseases, skin diseases, cancer, and inflammatory conditions. Another significant patent involves compositions and methods for anti-PACAP antibodies, which includes pharmaceutical compositions and methods for producing and using these antibodies.
Career Highlights
Julia Rozenfeld is currently associated with Cephalon, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to addressing critical health challenges through innovative solutions.
Collaborations
Julia has collaborated with notable colleagues, including Anthony Gerard Doyle and Adam Clarke, enhancing the scope and impact of her research.
Conclusion
Julia Rozenfeld's contributions to the field of biotechnology through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical treatments and therapies.